Antibiotic Prophylaxis for Cesarean Delivery: A Survey of Anesthesiologists
Table 3
Bivariate analysis of preincision antibiotic prophylaxis, adjunctive azithromycin for unscheduled cesarean delivery, and 3 g cefazolin in morbidly obese women.
Characteristic
Preincision prophylaxis (%)
value
Azithromycin use in intrapartum cesarean delivery (%)
value
3 g cefazolin in morbidly obese women (%)
value
Administration frequency of obstetric anesthesia
<0.0001
0.2286
0.6520
Very rarely (only a few times a year)
15/20 (75.0%)
1/20 (5.0%)
10/20 (50.0%)
Rarely (less than once a month)
31/38 (81.6%)
3/38 (7.9%)
13/38 (34.2%)
Occasionally (a few times a month)
453/475 (95.4%)
46/475 (9.7%)
202/475 (42.5%)
Very often (several times a week)
663/690 (96.1%)
91/690 (13.2%)
284/690 (41.2%)
Region in the United States
<0.0001
<0.0001
<0.0001
Northeast
240/248 (96.8%)
27/248 (10.9%)
97/248 (39.1%)
Southeast
219/233 (94.0%)
20/233 (8.6%)
86/233 (36.9%)
Midwest
238/245 (97.1%)
41/245 (16.7%)
123/244 (50.4%)
Southwest
116/118 (98.3%)
18/118 (15.3%)
57/118 (48.3%)
West
235/241 (97.5%)
32/241 (13.3%)
117/241 (48.6%)
Other
114/138 (82.6%)
3/138 (2.2%)
29/138 (21.0%)
Years in practice
0.0025
<0.0001
<0.0001
Currently training
4/4 (100.0%)
2/4 (50.0%)
3/4 (75.0%)
<5 years
106/107 (99.1%)
26/107 (24.3%)
68/107 (63.6%)
5–15 years
450/464 (97.0%)
68/464 (14.7%)
217/464 (46.8%)
More than 15 years
601/647 (92.9%)
45/647 (7.0%)
221/647 (34.2%)
Institutional annual number of cesarean deliveries
